{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:00:00Z","timestamp":1788901200673,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/dad.0b013e318177a423","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T07:14:16Z","timestamp":1221549256000},"page":"451-454","source":"Crossref","is-referenced-by-count":6,"title":["Vitiligo-like Primary Melanoma"],"prefix":"10.1097","volume":"30","author":[{"given":"A\u00edda","family":"Lugo-Somolinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda E","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","first-page":"1043","article-title":"Depigmentation cutanee associee au melanoma malin.","volume":"105","author":"Ortonne","year":"1978","journal-title":"Ann Dermatol Venereol"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-4632.2004.02468.x","article-title":"Regressing cutaneous malignant melanoma and vitiligo-like depigmentation.","volume":"45","author":"Arpaia","year":"2006","journal-title":"Int J Dermatol"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1346-8138.2006.00235.x","article-title":"Vitiligo associated with malignant melanoma and lupus erythematosus.","volume":"34","author":"Gul","year":"2007","journal-title":"J Dermatol"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.cmr.0000222590.68234.1d","article-title":"The course of melanoma-associated vitiligo: report of a case.","volume":"16","author":"Daneshpazhooh","year":"2006","journal-title":"Melanoma Res"},{"key":"R5-7-20210202","first-page":"443","article-title":"Vitiligo and cutaneous melanoma. A case study.","volume":"10","author":"Scallreuner","year":"1991","journal-title":"Dermatologica"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.1992.10.8.1338","article-title":"Sequential chemoimmunotherapy in the treatment of metastatic melanoma.","volume":"10","author":"Richards","year":"1992","journal-title":"J Clin Oncol"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(96)90707-0","article-title":"More on cutaneous reactions to recombinant therapy.","volume":"34","author":"Le Gal","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mpo.2950220208","article-title":"Therapy of disseminated malignant melanoma with recombinant 2b-interferon and piroxicam: clinical results with a report of an unusual response-associated feature (diffuse pulmonary interstitial fibrosis).","volume":"22","author":"Harris","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000075046","article-title":"A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma.","volume":"208","author":"Guillot","year":"2004","journal-title":"Dermatology"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archderm.1982.01650130038016","article-title":"Vitiligo or halo nevi occurring in two patients with choroidal melanoma.","volume":"118","author":"Albert","year":"1982","journal-title":"Arch Dermatol"},{"key":"R11-7-20210202","first-page":"63","article-title":"Uveal malignant melanoma with leucoderma.","volume":"16","author":"Nirankari","year":"1968","journal-title":"J All India Ophthalmol Soc"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1200\/JCO.1995.13.9.2401","article-title":"Immune-mediated and unusual complications during interferon alpha in chronic myelogenous leukemia.","volume":"13","author":"Sacchi","year":"1995","journal-title":"J Clin Oncol"},{"key":"R13-7-20210202","first-page":"289","article-title":"Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.","volume":"60","author":"Nouri","year":"1997","journal-title":"Cutis"},{"key":"R14-7-20210202","first-page":"522","article-title":"Vitiligo-like lesions in patients with melanoma treated with immunotherapy.","volume":"7","author":"Buendia-Eisman","year":"1997","journal-title":"Eur J Dermatol"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0736-8046.2004.21512.x","article-title":"Concomitant vitiligo and psoriasis in a patient treated with interferon alpha-2a for chronic hepatitis B infection.","volume":"21","author":"Seckin","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s002620050280","article-title":"Melanoma and vitiligo: immunologys Grecian urn.","volume":"42","author":"Berd","year":"1996","journal-title":"Cancer Immunol Immunother"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon.","volume":"354","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1046\/j.0022-202x.2001.01605.x","article-title":"Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.","volume":"117","author":"Le Gal","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000421-199612000-00017","article-title":"Melanoma-associated hypopigmentation: where are the antibodies?","volume":"19","author":"Merimsky","year":"1996","journal-title":"Am J Clin Oncol"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s002620050286","article-title":"Anti-tyrosinase antibodies in malignant melanoma.","volume":"42","author":"Merimsky","year":"1996","journal-title":"Cancer Immunol Immunother"},{"key":"R21-7-20210202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(05)61810-7","article-title":"Why tyrosinase for treatment of melanoma?","volume":"350","author":"Song","year":"1997","journal-title":"Lancet"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E","article-title":"Autoantibodies to tyrosinase, the bridge between melanoma and vitiligo.","volume":"79","author":"Fishman","year":"1997","journal-title":"Cancer"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"R24-7-20210202","first-page":"253","article-title":"Genetic vaccination with self tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.","volume":"60","author":"Bronte","year":"2000","journal-title":"Cancer Res"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1600-0749.2003.00038.x","article-title":"Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin?","volume":"16","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Pigment Cell Res"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","article-title":"Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.","volume":"113","author":"Becker","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.2005.00244.x","article-title":"Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?","volume":"18","author":"Garbelli","year":"2005","journal-title":"Pigment Cell Res"},{"key":"R28-7-20210202","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1087-0024.2004.00825.x","article-title":"Autoimmune aspects of depigmentation in vitiligo.","volume":"9","author":"Le Poole","year":"2004","journal-title":"J Invest Dermatol Symp Proc"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-4632.2006.03000.x","article-title":"Molecular analysis of vitiligo lesions reveals sporadic melanocyte survival.","volume":"46","author":"Gottschalk","year":"2007","journal-title":"Int J Dermatol"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2340\/00015555-0032","article-title":"Amelanotic melanoma-To be or not to be.","volume":"86","author":"Ladoyanni","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2559.1992.tb00988.x","article-title":"Histological regression in primary cutaneous melanoma: recognition, prevalence and syndrome.","volume":"20","author":"Blessing","year":"1992","journal-title":"Histopathology"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0b013e318177a423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T23:39:16Z","timestamp":1684539556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-200810000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e318177a423","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}